VANGUARD GROUP INC - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 14 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,180,171
-41.5%
5,675,7240.0%0.00%
Q2 2023$7,151,412
+73.2%
5,675,724
-0.4%
0.00%
Q1 2023$4,130,143
+37.2%
5,697,5360.0%0.00%
Q4 2022$3,011,147
-36.6%
5,697,536
+0.0%
0.00%
Q3 2022$4,746,000
-31.9%
5,694,747
-10.9%
0.00%
Q2 2022$6,969,000
-19.1%
6,393,267
-7.2%
0.00%
Q1 2022$8,616,000
-22.7%
6,892,416
-1.1%
0.00%
Q4 2021$11,153,000
-51.5%
6,970,850
-1.2%
0.00%
-100.0%
Q3 2021$23,004,000
-36.8%
7,056,461
+22.5%
0.00%0.0%
Q2 2021$36,420,000
+442.7%
5,762,626
+81.2%
0.00%
Q1 2021$6,711,000
+1264.0%
3,180,565
+513.9%
0.00%
Q4 2020$492,000
-2.6%
518,109
+148.0%
0.00%
Q3 2020$505,000
+10.0%
208,896
+73.1%
0.00%
Q2 2020$459,000
+185.1%
120,6890.0%0.00%
Q1 2020$161,000
-14.8%
120,6890.0%0.00%
Q4 2019$189,000
-20.3%
120,6890.0%0.00%
Q3 2019$237,000
-23.1%
120,6890.0%0.00%
Q2 2019$308,000
+25.7%
120,689
+73.7%
0.00%
Q1 2019$245,000
+250.0%
69,489
+0.8%
0.00%
Q4 2018$70,000
+18.6%
68,917
+103.5%
0.00%
Q3 2018$59,000
-21.3%
33,8640.0%0.00%
Q2 2018$75,00033,8640.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 524,805$572,0000.39%
Laurion Capital Management LP 2,225,800$2,426,0000.04%
Ergoteles LLC 514,600$561,0000.02%
Pinz Capital Management, LP 17,900$20,0000.01%
Alpine Global Management, LLC 37,089$40,0000.01%
Game Plan Financial Advisors, LLC 10,000$11,0000.01%
Spire Wealth Management 100,300$109,0000.00%
Renaissance Technologies 1,989,995$2,169,0000.00%
D. E. Shaw & Co., Inc. 2,279,636$2,485,0000.00%
Y-Intercept (Hong Kong) Ltd 16,912$18,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders